Orion OYJ (OTCMKTS:ORINY) Sees Large Volume Increase – Should You Buy?

Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) shares saw an uptick in trading volume on Tuesday . 521 shares changed hands during trading, an increase of 152% from the previous session’s volume of 207 shares.The stock last traded at $38.6150 and had previously closed at $39.00.

Orion OYJ Trading Up 0.9%

The company has a market cap of $11.11 billion, a price-to-earnings ratio of 18.05 and a beta of 0.08. The company has a quick ratio of 1.13, a current ratio of 1.77 and a debt-to-equity ratio of 0.10. The company’s 50-day moving average is $38.02 and its 200 day moving average is $38.07.

Orion OYJ (OTCMKTS:ORINY) last released its quarterly earnings results on Thursday, April 23rd. The company reported $0.37 EPS for the quarter. The company had revenue of $488.80 million for the quarter. Orion OYJ had a net margin of 27.14% and a return on equity of 49.17%.

Orion OYJ Company Profile

Orion Corporation (Orion Oyj) is a Finland-based pharmaceutical company engaged in the research, development, manufacture and marketing of human and veterinary medicines as well as diagnostic tests. The company’s core therapeutic areas include central nervous system disorders, oncology and respiratory diseases, and it offers both proprietary and generic products. Orion’s product range spans from small-molecule drugs and active pharmaceutical ingredients to radiodiagnostic imaging agents and line extensions developed through in-house research.

Since its founding in 1917 in Helsinki, Orion has grown into an integrated pharmaceuticals business with state-of-the-art manufacturing facilities in Finland and France.